Evidence map›Paper›PMID 27454357›Full record

ArticleBMC bioinformatics2016

Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches.

Mark T W Ebbert, Mark E Wadsworth, Lyndsay A Staley, Kaitlyn L Hoyt, Brandon Pickett, Justin Miller, John Duce, Alzheimer’s Disease Neuroimaging Initiative, John S K Kauwe, Perry G Ridge

Abstract read
In one paragraph

Article in BMC bioinformatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed.

  1. Trial
  2. Article
  3. A recurrentBiochemistry and biophysics reports · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Multi-Tissue Genetic Regulation of RNA Editing in Pigs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Polymorphisms and Expression Characteristics of theAnimals : an open access journal from MDPI · 2026
    Article
  9. Article
  10. Article
  11. RecessiveDiagnostics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mark T W EbbertDepartment of Biology, Brigham Young University, Provo, UT, USA.
Mark E WadsworthDepartment of Biology, Brigham Young University, Provo, UT, USA.
Lyndsay A StaleyDepartment of Biology, Brigham Young University, Provo, UT, USA.
Kaitlyn L HoytDepartment of Biology, Brigham Young University, Provo, UT, USA.
Brandon PickettDepartment of Biology, Brigham Young University, Provo, UT, USA.
Justin MillerDepartment of Biology, Brigham Young University, Provo, UT, USA.
John DuceDepartment of Biology, Brigham Young University, Provo, UT, USA.
Alzheimer’s Disease Neuroimaging Initiative
John S K KauweDepartment of Biology, Brigham Young University, Provo, UT, USA.
Perry G RidgeDepartment of Biology, Brigham Young University, Provo, UT, USA. perry.ridge@byu.edu.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Research Supplements to Promote Diversity in Health-Related ResearchR01AG042611 · NIA · BRIGHAM YOUNG UNIVERSITY · PI KAUWE, JOHN SAI KEONG · 2012 to 2017
$1.5M
NIA NIH HHS R01 AG042611NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

backgroundAnalyzing next-generation sequencing data is difficult because datasets are large, second generation sequencing platforms have high error rates, and because each position in the target genome (exome, transcriptome, etc.) is sequenced multiple times. Given these challenges, numerous bioinformatic algorithms have been developed to analyze these data. These algorithms aim to find an appropriate balance between data loss, errors, analysis time, and memory footprint. Typical analysis pipelines require multiple steps. If one or more of these steps is unnecessary, it would significantly decrease compute time and data manipulation to remove the step. One step in many pipelines is PCR duplicate removal, where PCR duplicates arise from multiple PCR products from the same template molecule binding on the flowcell. These are often removed because there is concern they can lead to false positive variant calls. Picard (MarkDuplicates) and SAMTools (rmdup) are the two main softwares used for PCR duplicate removal.

resultsApproximately 92 % of the 17+ million variants called were called whether we removed duplicates with Picard or SAMTools, or left the PCR duplicates in the dataset. There were no significant differences between the unique variant sets when comparing the transition/transversion ratios (p = 1.0), percentage of novel variants (p = 0.99), average population frequencies (p = 0.99), and the percentage of protein-changing variants (p = 1.0). Results were similar for variants in the American College of Medical Genetics genes. Genotype concordance between NGS and SNP chips was above 99 % for all genotype groups (e.g., homozygous reference).

conclusionsOur results suggest that PCR duplicate removal has minimal effect on the accuracy of subsequent variant calls.

Indexed as

Polymorphism, Single NucleotideSoftwareData AccuracyGenome, HumanGenomicsHigh-Throughput Nucleotide SequencingHumansPolymerase Chain ReactionSequence Analysis, DNANext-Generation SequencingPCR duplicate removalPicardSAMTools

Identifiers

PMID27454357
PMCPMC4965708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.